Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Congress
Safe Step Act of 2021 Introduced in the Senate
In late February 2021, Senators Lisa Murkowski, Maggie Hassan, Bill Cassidy, Jacky Rosen, and nine other bipartisan co-sponsors…
A New Hurdle for Mental Health Care Provided Via Telemedicine?
Over the last year, we have seen major changes happen to federal and state telemedicine and digital health laws, including…
What Does the Consolidated Appropriations Act Mean to Industry?
On December 27, President Trump signed into law the Consolidated Appropriations Act, 2021, which was passed by Congress the…
Senate Finance Committee Report Calls for Greater Drug Industry…
On December 16, 2020, Senate Finance Committee Chairman Chuck Grassley and Ranking Member Ron Wyden released a report to the…
House Oversight Committee Subpoenas AbbVie in Drug Pricing Probe
On September 1, 2020, Carolyn B. Maloney, Chairwoman of the United States House of Representatives Committee on Oversight and…
E&C Subcommittee on Health Holds Hearing on Health Care Inequality
On June 17, 2020, the Health Subcommittee of the United States House of Representatives’ Committee on Energy and Commerce held a…
Senate Finance Committee Releases Updated Drug Pricing Bill and Extender…
Recently, Senator Chuck Grassley and Senator Ron Wyden released an updated version of their drug pricing legislation, including…
Feedback Solicited for Cures 2.0
United States Representatives Diana DeGette (D-CO) and Fred Upton (R-MI), the lead authors of the 21st Century Cures Act, recently…
US House HELP Committee Debates Pelosi’s Drug Pricing Bill
Recently, the House Health, Employment, Labor and Pensions (“HELP”) Subcommittee held a hearing to consider testimony and discuss…
House Committee Releases International Drug Pricing Comparison Report
On September 23, 2019, the House Ways & Means Committee released a report outlining and comparing the pharmaceutical pricing…